Strategies for containing an emerging infectious disease outbreak must be nonpharmaceutical when drugs or vaccines for the pathogen do not yet exist or are unavailable. The success of these non-pharmaceutical strategies will depend not only on the effectiveness of quarantine or other isolation measures but also on the epidemiological characteristics of the infection. However, there is currently no systematic framework to assess the relationship between different containment strategies and the natural history and epidemiological dynamics of the pathogen. Here, we compare the effectiveness of quarantine and symptom monitoring, implemented via contact tracing, in controlling epidemics using an agent-based branching model. We examine the relationship between epidemic containment and the disease dynamics of symptoms and infectiousness for seven case study diseases with diverse natural histories including Ebola, Influenza A, and Severe Acute Respiratory Syndrome (SARS). We show that the comparative effectiveness of symptom monitoring and quarantine depends critically on the natural history of the infectious disease, its inherent transmissibility, and the intervention feasibility in the particular healthcare setting. The benefit of quarantine over symptom monitoring is generally maximized for fast-course diseases, but we show the conditions under which symptom monitoring alone can control certain outbreaks. This quantitative framework can guide policy-makers on how best to use non-pharmaceutical interventions to contain emerging outbreaks and prioritize research during an outbreak of a novel pathogen.
SIGNIFICANCE
Quarantine and symptom monitoring of contacts with suspected exposure to an infectious disease are key interventions for the control of emerging epidemics; however, there does not yet exist a quantitative framework for comparing the control performance of each.
Here, we use a mathematical model of seven case study diseases to show how the choice of intervention is influenced by the natural history of the infectious disease, its inherent transmissibility, and the intervention feasibility in the particular healthcare setting. We use this information to identify the most important characteristics of the disease and setting that need to be characterized for an emerging pathogen in order to make an informed decision between quarantine and symptom monitoring.
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INTRODUCTION
The global burden of emerging infectious diseases is growing and prompts the need for effective containment policies (1) (2) (3) . In many cases, strategies must be nonpharmaceutical, as targeted drugs or vaccines for the pathogens are unavailable. Among the various containment strategies, isolation of ill and potentially infectious patients is one of the most intuitive, relying on the tracing the contacts of known cases. Contacts with symptoms can then be hospitalized or isolated, but policy makers must also decide how best to handle contacts that do not meet the case definition for infection. Two strategies have historically been used in the case of a potentially infected but symptom-free contact:
quarantine and symptom monitoring.
Quarantine of potentially infected contacts during an epidemic is highly conservative with respect to efficacy, but it comes at a high cost. Costs associated with quarantine policies range from direct (e.g., implementation expenses and the restriction of personal liberties) to indirect (e.g., stigmatization of health workers and sometimes interruption of financial and trade markets) (4) (5) (6) (7) (8) . A less conservative but substantially cheaper and more socially palatable approach is active symptom monitoring of contacts. In this strategy, health workers check on contacts one or two times a day and isolate them if symptoms occur (see definitions in Methods).
Given the importance of rapid decision making in the event of novel emerging pathogens, and the potentially devastating consequences of poor containment strategies, quantitative guidelines are urgently needed for deciding whether quarantine is, according to Gates et al., at worst "counterproductive" or at best "one of the few tactics that can reduce its spread" (9) . Current guidance on the use of quarantine or symptom monitoring is ad hoc and disease-specific, lacking the generalizability required for rapid decisionmaking for novel pathogens and leading to confusion during implementation (10) (11) (12) .
During the Severe Acute Respiratory (SARS) epidemic, broad quarantine interventions were applied in Taiwan and subsequently abandoned (13) . Furthermore, we are aware of no framework that considers the implementation setting as a factor for intervention choice or performance, despite its obvious importance. Indeed, the United States Centers for Disease Control and Prevention (CDC) implicitly recognized the value of implementation setting by differentiating its international response, where quarantine was prioritized (14) , and its domestic response, where symptom monitoring was prioritized (15, 16) .
The success of these approaches is not simply a reflection of the efficiency of their implementation but crucially depend on the biology and natural history of the pathogen in question. Previous theoretical work by Fraser, et al. (17) summarized these dynamics into a measure of the proportion of infections by asymptomatic infection ( ) and the basic reproductive number ( ! ), defined as the average number of infections generated by an infectious individual in a fully susceptible population. Subsequent work has explored the interaction between disease characteristics (e.g., super-spreading (18) ) and the performance of interventions (e.g., travel screening (19) ), but the recent Ebola epidemic demonstrated that at least two large questions remain (7) . Firstly, what is the role of symptom monitoring as an alternative to quarantine, and secondly, how does this choice depend on the characteristics of the disease, the setting, and their interactions?
Here we develop an agent-based branching model that accommodates realistic distributions of disease characteristics and maintain the infector-infectee correlation 6 structure necessary for interventions targeted via contact tracing. To assess diseases with a wide range of natural histories that have the potential for causing sudden, severe epidemics, we consider case studies of seven known pathogens: Ebola; hepatitis A; influenza A; Middle East Respiratory Syndrome (MERS); pertussis; SARS; and smallpox. We identify which disease characteristics and intervention attributes are most critical in deciding between quarantine and symptom monitoring, and provide a clear, general framework for understanding the consequences of isolation policies during an epidemic of known or novel pathogens.
.
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RESULTS
Intervention Effectiveness Depends on Disease Epidemiological Dynamics.
To assess the impact of quarantine and symptom monitoring, we developed a general mathematical model of disease transmission and interventions targeted via contact tracing (Fig 1) . The model structure accommodates five key metrics of intervention performance in a given setting ( Table 1) . We used particle filtering to generate parameter sets consistent with seven case studies of outbreak-prone pathogens (see Methods and Table 2 ). (Figs 2A-B) . Under a given intervention policy, we estimate the effective reproductive number (Re) as the average number of infections generated by an infectious individual in the population. The effective reproductive number under symptom monitoring (RS), quarantine (RQ), and the absolute difference between the two ( ! − ! ) increases with R0 and differs by disease (Figs 2C-D) .
We find the effectiveness of symptom monitoring and quarantine in controlling a disease in a particular setting depends critically on its biological dynamics (e.g. latent and infectious periods) and transmissibility ( ! ) (Fig 3a) . Holding transmissibility constant ( ! arbitrarily set to 2.75±0.25), biological dynamics alone strongly influence the effectiveness . CC-BY-ND 4.0 International license is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It . https://doi.org/10.1101/072652 doi: bioRxiv preprint of quarantine and especially symptom monitoring, as seen by the wide spread in ! (Fig   3b) .
In simulations with high intervention performance settings (i.e., 90% isolation effectiveness, 90% of contacts traced within one day, and symptoms monitored daily), diseases such as MERS and Ebola could be controlled (i.e., Re < 1) with either quarantine or symptom monitoring; diseases such as hepatitis A with only quarantine; but diseases such as pertussis require additional interventions in order to reduce the effective reproductive number below one, due in large part to pre-symptomatic infectiousness (Fig 3c) . The absolute comparative effectiveness ( ! − ! ) varies widely by disease, as demonstrated by the line length in Fig 3c. The relative comparative effectiveness (
) also varies widely, with quarantine reducing RS by over 65% for influenza A and hepatitis A and by less than 10% for pertussis (Fig S1) . The reader can explore results from landscapes with different intervention performance settings and disease transmissibility in the interactive supplement (https://coreypeak.shinyapps.io/InteractiveQuarantine).
Categorizing Disease Control Frontiers
In order to compare the effectiveness of symptom monitoring and quarantine, one must select an appropriate metric to compare RS and RQ. We therefore categorized intervention response heterogeneity into four control quadrants (Fig 3a) . In quadrant I, where neither intervention is sufficient to prevent epidemic growth, the relative difference
can distinguish whether quarantine is merited or could be paired with other strategies to achieve control. Because quarantine is by definition the more conservative . CC-BY-ND 4.0 International license is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It . https://doi.org/10.1101/072652 doi: bioRxiv preprint intervention, simulation results in quadrant II occur only stochastically. In quadrant III, where both interventions are sufficient and the number of prevented cases can be more directly estimated, the distinguishing metric was the absolute difference ! − ! and its inverse (
, which can be interpreted as the number of contacts that must be quarantined in order to prevent one additional case over symptom monitoring (an analog of "number needed to treat"). For the example of SARS, Day et al. propose that mass quarantine may be unnecessary because effective symptomatic isolation alone would sufficiently control the disease (hence placing the disease in quadrant III) (8) . In quadrant IV, where quarantine but not symptom monitoring can control the disease, quarantine would be strongly considered as the minimum sufficient strategy to prevent exponential epidemic growth.
The following two sections aim to identify which disease characteristics and intervention performance metrics most strongly influence these differences in response to quarantine and symptom monitoring.
Ranking of epidemiological characteristics by importance for containment feasibility
The comparative effectiveness of quarantine and symptom monitoring is strongly influenced by differences in the infection's natural history. We measured partial rank correlation coefficients to examine which biological characteristics in particular are most influential after controlling for the other characteristics (Methods). As demonstrated by strongly negative partial rank correlation coefficients in Fig 4, increasing the duration of infectiousness ( !"# ) and elongating the latent period ( !""#$% ) reduced the differences between quarantine and symptom monitoring, thereby making the interventions more . CC-BY-ND 4.0 International license is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It . https://doi.org/10.1101/072652 doi: bioRxiv preprint similar. Other factors, such as overdispersed heterogeneity of the basic reproductive number ( ), did not influence the average effect of symptom monitoring and quarantine, as reflected by a coefficient of nearly zero. However, at a given effective reproductive number, overdispersion does decrease the average number of generations until extinction, as predicted (Fig S2) (18) . Longer incubation periods (TINC) increased the preference for quarantine, as seen by the positive partial rank correlation coefficient for both absolute and relative comparative effectiveness. However, the length of the incubation period does not generally influence comparative effectiveness per quarantine day because the number of days in quarantine ( ! ) increases as the incubation period lengthens (Fig S3) .
Frequently, the most politically and economically pressing concerns are whether control (i.e. ! < 1) is logistically achievable and what would be the least invasive intervention to achieve control. Ebola. When R0 is large and symptoms emerge long after infectiousness (e.g., !""#$% > 0), even quarantine is insufficient to control the disease with optimal intervention performance. However, we observe that when transmissibility is relatively low (e.g., ! < 2.5), control of this hypothetical disease can be achieved even if infectiousness precedes symptoms by several days (Fig 5a) or if a substantial fraction of transmission events occur before symptom onset (adapting the framework of (17)) (Fig 5b) .
Ranking of intervention performance metrics by importance for containment feasibility
Policy makers facing an epidemic must also consider the expected performance of interventions, since the effectiveness of targeted control policies will depend on their feasibility within a particular healthcare system. Generally, we found the benefit of quarantine over symptom monitoring increases with better intervention performance (i.e. larger fraction of contacts traced ( !" ), better isolation effectiveness ( ), and shorter delays in tracing a contact ( !! ) (Fig 4) . However, the effectiveness of symptom monitoring approached that of quarantine when the delay between symptom onset and isolation ( !" ) is shortened, due either to more frequent symptom monitoring or more sensitive detection of symptoms followed by prompt isolation.
While these patterns were highly consistent across the case study diseases, some intervention performance metrics were particularly influential in the presence of certain disease characteristics. For example, diseases with short incubation periods ( !"# ) such as influenza A were strongly influenced by delays in tracing a contact ( !" ) (Fig S3) .
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DISCUSSION
A key strategy to controlling the spread of infectious diseases focuses on tracing the contacts of infected individuals, with the goal of limiting subsequent spread should those contacts become infectious. Here, we present the first study comparing the effectiveness of the two primary non-pharmaceutical interventions targeted via contact tracing: symptom monitoring and quarantine. We show that the interventions are not equivalent and that the choice of which intervention to implement to achieve optimal control depends on the natural history of the infectious disease, its inherent transmissibility, and the intervention feasibility in the particular healthcare setting.
Our results show that the benefit of quarantine over symptom monitoring is maximized for fast-course diseases (short duration of infectiousness and a short latent period compared to the incubation period), and in settings where isolation is highly effective, a large fraction of contacts are traced, or when there is a long delay between symptom onset and isolation. This delay ( !" ) not only captures ineffective symptom monitoring, but also the potential for symptoms to be masked for a period of time through biological (e.g., natural disease progression or self-medication with anti-pyretics) or behavioral (e.g., avoidance) mechanisms. In contrast, the widely-discussed "super spreading" disease characteristic did not independently impact the mean comparative effectiveness of interventions after holding R0 constant. However, this characteristic could remain important to understand disease control during highly stochastic stages of emergence and extinction (Fig S2) (18) . Our findings are consistent with Fraser, Riley, et al.
(17) that both inherent transmissibility and the proportion of transmission from .
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In addition to identifying parameters that differentiate quarantine and symptom monitoring, our results also characterize parameter spaces where symptom monitoring, not just quarantine, is sufficient for containment of an emerging epidemic. Given the high costs and poor scalability of quarantine, symptom monitoring is likely to be a key intervention for future epidemic containment.
The CDC has current legal authority to quarantine for diseases including Ebola, SARS, MERS, smallpox, and influenza strains with pandemic potential (12) . Our results support the retention of quarantine as a live-option for each of these diseases, but only if control is infeasible through symptom monitoring (i.e. ! < 1 < ! ) and other lessinvasive means, which sometimes include vaccination, prophylaxis, and social distancing.
We find that the incremental benefit of quarantine over symptom monitoring is small for Ebola and SARS, but relatively large for influenza, whose short duration of infectiousness ( !"# ≈ 1-3 days) and some pre-symptomatic infectiousness ( !""#$% < 0) render symptom monitoring a generally ineffective intervention -particularly in settings with slow contact tracing ( !" >> 0) and symptom identification ( !" >> 0). For pandemic influenza strains (which are expected to have higher ! than the seasonal influenza strains shown here) or if circumstances arise such that MERS transmissibility increases substantially, quarantine may be necessary to achieve control (Fig 3B) . Note that CDC quarantine authorities do not extend to pertussis and hepatitis A, and these case studies were selected to demonstrate a broad range of natural histories and transmission routes, including bodily fluid, fecal-oral, and airborne, which will influence the contact networks .
The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It . https://doi.org/10.1101/072652 doi: bioRxiv preprint and traceability of contacts. In general, we find that a reduction in the fraction of contacts who are ultimately traced will decrease the preference for quarantine over symptom monitoring, therefore supporting the previous findings that quarantine was inefficient for a respiratory disease like SARS (20).
Although our results focus on the early stages of an outbreak, contact tracing, symptom monitoring, and quarantine are often key tools for end-stage epidemic control and elimination. As the effective reproductive number decreases below one (e.g. via depletion of susceptible individuals, complementary interventions, seasonality, etc.), our results suggest the preference for quarantine also decreases (Fig 4) . However, one must consider aspects such as geographic containment, public compliance, and, if the availability of resources lags the epidemic curve, a possible resource-per-case surplus that may enable the more conservative and costly approach of quarantine.
Our results suggest that symptom monitoring could effectively control an outbreak of a new Ebola-like disease, even when infectiousness precedes symptoms and interventions are not perfectly implemented. Because perfect interventions are not always necessary, these results support the conclusion of Cetron et al. (21) that the optimal containment strategy may allow "partial or leaky quarantine" in order to increase the fraction of contacts who participate.
We propose that the most influential parameters should be prioritized for early characterization during an outbreak (22) and should be modeled with conservative consideration of parameter uncertainty, including both real diversity and measurement error. Our framework identifies the key infection-related parameters to define and can .
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METHODS
Definitions
"Contact Tracing" is the process of identifying and assessing people who have been exposed to a disease (23). Contacts who are symptomatic when traced are immediately placed in isolation; those who are not symptomatic are placed under either quarantine or symptom monitoring. Here, we model "forward" contact tracing whereby an infected individual names contacts they may have infected (24).
"Isolation" is the separation of a symptomatic individual believed to be infected (23). By reducing the number of risky contact events, isolation reduces disease transmission when infectiousness coincides at least partly with symptoms.
"Quarantine" is the separation of an individual who is believed to be exposed, but is currently not ill (23). If an individual becomes symptomatic, they will be isolated and receive healthcare.
"Symptom Monitoring" is the assessment of symptoms at regular intervals of an individual believed to be exposed, but not ill. If symptoms are detected, the individual is placed in isolation (23). Although they may be encouraged to avoid interpersonal contacts, an individual under symptom monitoring is not separated from others and therefore does not experience a reduction in risky contacts until symptoms are detected.
"Health Seeking Behavior" is the act of seeking healthcare during the presentation of symptoms, leading to isolation. Practically, this intervention could be a health education campaign that prompts individuals to self-identify illness and seek effective isolation. This intervention, which accelerates isolation in a manner separate from contract tracing, provides a comparative care standard for our analysis.
Model
Individuals in our branching model progress through a Susceptible-ExposedInfectious-Recovered (SEIR) disease process. We focus our analysis on the early epidemic phase of an emerging infectious disease, assuming no changes to herd immunity within the first few generations of transmission.
Following infection, the number of days before onset of infectiousness and onset of symptoms are the latent period and incubation period, respectively (Fig 1) . Because The recent SARS and Ebola epidemics highlighted that hospital isolation does not always contain transmission; we therefore allow isolation effectiveness (γ) to vary to reflect different settings (17, 26, 27) . The fraction of contacts who are traced (PCT) can be less than 1, encompassing symptomatic infectors who fail to recall contacts, asymptomatic "silent" infection events, reluctance to report contacts, and challenges in identifying contacts, especially for airborne transmission routes. Imperfections and uncertainties in risk profiling can reduce the fraction of traced contacts that are truly infected (PINF) (16, 20) . Delays in tracing a contact (DCT) can arise for numerous reasons, including intractable roads, low mobile phone penetration, and personnel limitations. The delay between symptom onset and isolation (DSM) specifically applies to individuals under symptom 
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Parameterization
As compared to characteristics related to the natural history of symptoms and illness, key aspects of the natural history of infectiousness tend to be harder to observe and measure (28). Therefore, we use a Sequential Monte Carlo particle filtering algorithm (29, 30) to create a joint probability space of the time offset between the latent period and incubation period ( !""#$% = !"# − !"# ), time of peak infectiousness ( ! ), and duration of infectiousness ( !"# ). From an uninformative prior distribution of each parameter bounded by published observations, we simulate five infection generations of 500 initial individuals and record the simulated serial interval (i.e., the time between symptom onset in infector-infectee pairs). Parameter sets are resampled with importance weights determined by the degree to which the distribution of simulated serial intervals match published serial interval distributions, using the Kolmogorov-Smirnov test of the difference between cumulative distribution functions (Table 2) (31, 32). After perturbation, the process is repeated until convergence, which we define to be when the median Kolmogorov-Smirnov statistic was within 10% of the previous two iterations. This cutoff criterion balances the objectives of finding a stationary posterior set of particles while preserving some of the heterogeneity in input parameters.
Holding the incubation period distribution constant, we fit an offset for the latent period ( !""#$% ) for several reasons, including consistency with CDC methods for disease characterization (33), the biological expectation of these timings both being linked to pathogen load, and to parsimoniously limit each characteristic to one interpretable parameter. For the duration of infectiousness ( !"# ), we fit the upper bound of a uniform .
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Analysis
Partial rank correlation coefficients are calculated to identify the most influential disease characteristics (e.g. duration of infectiousness) and intervention performance metrics (e.g. isolation effectiveness). In order to remove dependence between the parameters jointly fit through the particle filtering method above, we use Latin Hypercube Sampling to draw 5,000 sets from each marginal posterior parameter distribution independently. To maximize coverage of the parameter space we allowed fractional parameters (γ, PCT, PINF, ) to range from 0 to 1, delays (DCT, DSM) to range from 0 to 7 days, ! to range from 1 to 5, and the incubation period ( !"# ) to be shrunk by up to 50% or stretched by up to 150%.
We draw 1,000 samples from the joint-parameter space from the particle filtering method and measure R0, RQ, RS, and RHSB for each disease. We compare the effectiveness of symptom monitoring and quarantine by the absolute difference ( ! − ! ) and the relative difference (
). We calculate the number of days an infected individual was in quarantine but not yet infectious ( ! ) as surrogate for the marginal cost of quarantine over symptom monitoring. As abstract surrogates for cost-effectiveness, we calculate the absolute difference per quarantine day ! − ! ! and relative difference per .
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! and present these results in Figs S1 and S3. More concrete measures of cost-effectiveness would require economic and social considerations that are outside the scope of this paper.
When risk profiling is imperfect (i.e. PINF < 1), uninfected individuals may be mistakenly traced as contacts and placed under symptom monitoring or quarantine. Such events may be conceptualized as false positives and will decrease PINF; conversely, individuals who are infected but not traced are false negatives and will decrease PCT. We assume that non-infected contacts are followed for a length of time set up the 95 th percentile incubation period ( !"# !" ), at which point health authorities may conclude the contact was not infected after all. This changes the number of days in quarantine to
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Fig 1. Schematic of the natural history of disease and the timing of interventions.
Beginning on the left with the infection event, one progress through a latent period (TLAT) before becoming infectious for dINF days with late peak infectiousness ! . For diseases A, B, and C, symptoms are respectively shown to emerge before, concurrent with, and after onset of infectiousness. We show here an individual who is traced shortly after infection and is placed under symptom monitoring or quarantine after a short delay DCT.
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S1 Appendix. Disease model
The model simulates a branching network of infected individuals only. An individual is assigned characteristics sampled from distributions defined for each disease ( Table  S1 ). The incubation period ( !"# ), i.e. the time from infection to symptom onset, is drawn from published distributions ( Table 2 ). The duration of infectiousness ( !"# ), time of peak infectiousness ( ! ), and time offset between the ends of the latent and incubation periods ( !""#$% ) are drawn from the joint posterior distribution generated by the sequential Monte-Carlo (SMC) particle filtering method described in S2 Appendix. For clarity, we describe the method for an individual , but the following process is repeated for an initial population of 1,000 individuals who each initiate distinct trees.
The expected number of onward infections by individual , ! ! , is distributed over each hour of disease ! ! = ! ! ! ! , where ! ! is the relative infectiousness of individual on hour such that (Fig S6) . For parsimony and ease of interpretation, we assume ! ! follows a discretized triangle distribution with a peak value at time ! drawn from the SMC posterior and rounded to the nearest hour. When 0 < ! < !"# , ! ! is defined by a piecewise function according to whether is in the period before the peak of infection ( ≤ ! ) or τ is after the peak of infection:
Infectiousness after the peak is scaled by , which is the slope of the post-peak infectiousness line:
In order to normalize ! ! to sum to 1, each piecewise component is divided by , which is defined as the sum of infectiousness before the peak and after the peak:
Under the simple conditions of linearly increasing or decreasing infectiousness, ! ! is respectively defined by
The total number of infections ( ! ) generated by individual is drawn from a negative binomial distribution with mean equal to the total expected number of infections .
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If individual i generates infections (i.e., ! > 0), then each infection generated is assigned to a particular time drawn from a random sample 0,1, … , !"# ! that is weighted by ! ! ! ! so that hours of high infectiousness are more likely to have larger values of ! ! . Therefore, each individual i has a vector of ! ! , ! ! , … , ! !"# ! of onward infections that occur during each hour of their infectiousness. A new individual is generated for each onward infection ! ! ≥ 1. Disease characteristics for individual are drawn as above and are set to begin at the time of infection of individual j.
Each individual j will be traced with probability !" . If traced, individual is placed under symptom monitoring or quarantine after an operational lag time of !" days. The lag time occurs after the earlier of: (1) isolation of individual i or (2) removal of individual i from the disease system upon recovery or death. We assume individuals granted access to the quarantine or isolation room will be logged and given the same attention as contacts traced through epidemiological interview and will therefore will begin monitoring or quarantine at the time of the infection control breach or transmission event.
Next we determine the time of isolation for individual . If time of symptom onset for individual occurs before individual is traced, individual is immediately isolated. Otherwise, time of isolation for individual depends on whether symptom monitoring or quarantine is used. Under symptom monitoring, isolation of individual occurs a delay !" days after symptom onset. Note that for contacts checked twice-daily, !"~u nif(0, 0.5). Upon isolation, the hourly expected number of onward infections is reduced to ! ! = (1 − ) ! ! ! ! where is effectiveness of isolation with support 0, 1 . If individual is under quarantine, then ! ! is reduced by (1 − ) beginning at the time individual is traced.
S2 Appendix. Parameterization via Sequential Monte Carlo
We used the following method to generate parameter sets that are consistent with the published serial interval and incubation period distributions for each case study disease. The objective of this procedure is not explicitly parameter inference, for which raw data and disease-specific nuance is necessary, but rather a range of parameters to reflect the heterogeneity of each disease in a common framework. Data-informed incubation period and serial interval distributions were collected through a literature review. Sequential Monte-Carlo (also known as particle filtering) methods were used to estimate the joint distribution of three disease parameters ( !""#$% , !"# , and ! ) using knowledge of the incubation period and serial interval distributions [28, 29] .
Here we assume that the latent period for an individual ends some time ( !""#$% ) before (TOFFSET < 0) or after (TOFFSET > 0) the onset of symptoms. Therefore, !""#$% is a translation of the incubation period distribution. We assume a uniform distribution of duration of infectiousness from 1 day to !"# , by hour. We assume the distribution of relative infectiousness to follow a triangle distribution with a peak at time ! , which ranges from 0 (indicating infectiousness is linearly decreasing) to 1 (indicating infectiousness is linearly increasing).
The steps are as follows:
i.
Use the "lhs" package in R to create a Latin Hypercube sample of 1000 parameter sets ! , ! , … , !""" consisting of !""#$% , !"# , and ! , which are bounded by the range of the parameter values found in the literature ( Table 2) , ii.
Draw a parameter set ! = ! iii.
Under parameter set ! , run the branching epidemic model beginning with 500 distinct infections under a situation with no interventions. iv.
Use the two-sample "ks.test" function in R to calculate the KolmogorovSmirnov ( ! ) test statistic comparing the empirical distribution of simulated serial intervals to the published serial interval distribution (Fig S4) . v.
Repeat steps (iii-iv) for each parameter set ! = ! , ! , … , !""" . vi.
Set an adaptive threshold KS* equal to 80% of the maximum ! among the 1000 parameter sets above. vii. Create a set of 1000 Θcandidate parameter sets by selecting a weighted sample with replacement from all parameter sets ! with KSi ≤ KS*. Weights are proportional to
viii. Perturb each Θcandidate by between 0% and 2% (uniformly) of the initial parameter value range. ix. Repeat steps (ii)-(viii) until the median KS is within 10% of each of the previous two rounds.
It is widely known that generation intervals are difficult to observe in nature, but challenges also arise in measurements of generation intervals in simulations. For example, generation time distributions may change over the course of an epidemic due to depletion . CC-BY-ND 4.0 International license is made available under a The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It . https://doi.org/10.1101/072652 doi: bioRxiv preprint of the susceptible individuals (1). Analogous to the approach of (2), our method of direct observation of simulated serial intervals is restricted to the exponential growth period of an epidemic, as produced by a branching model. However, the potential for the length of generation intervals to be under-estimated near the peak of an epidemic can cause a downward bias in the published serial intervals upon which our parameterization methods are based (2, 3) . Therefore, this downward bias can result in a bias towards "faster" disease parameters (namely, a leftward bias in !""#$% , !"# , and ! ). Such a bias would reduce the simulated effectiveness of all interventions considered in this paper. DCT has a rather large negative effect on RS-RQ. Note that pooled estimates for comparative cost-effectiveness are not available due to non-monotonic relationships across diseases.
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